Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 62Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3Recurrence 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Hodgkin Disease 1

Interventions

Gene Expression Profiling 11Surveys and Questionnaires 9Polymerase Chain Reaction 9Immunohistochemistry 9Amplified Fragment Length Polymorphism Analysis 9Flow Cytometry 8Psychiatric Rehabilitation 7Microarray Analysis 6Rituximab 5Interviews as Topic 4Cytogenetic Analysis 4Blood Specimen Collection 4Biopsy 4Therapeutics 3Immunologic Techniques 3Gene Rearrangement 3Drug Therapy 3Doxorubicin 3Data Collection 3Cyclophosphamide 3plerixafor 2Vincristine 2Prednisone 2Positron-Emission Tomography 2Phlebotomy 2Pharmacogenomic Testing 2Observation 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphoma × Bendamustine Hydrochloride × Clear all
NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Ruijin Hospital

Recruiting
332 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡